D R A F T
National ART Surveillance System
NASS 2.0
(Proposed for 2016)
DRAFT
INITIAL REPORTING: PATIENT PROFILE (prosPEctive)
| Quex ID | LEAD QUESTION | ||
| 1 | Date of cycle reporting (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | ||
| 2 | NASS Patient ID: |__|__|__|__| - |__|__|__|__| - |__|__| | ||
| 3 | Patient Optional Identifiers Optional Identifier 1 |__|__|__|__|__|__|__| maximum 7 digits or characters | ||
| 
				 | 
				 Optional Identifier 2 |__|__|__|__|__|__|__| maximum 7 digits or characters | ||
| 4 | Patient Date of Birth (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | ||
| 5 | Sex of patient: ⃝ Male ⃝ Female | ||
| 6 | Cycle Start Date|__|__| - |__|__| - |__|__|__|__| | ||
| 
				 | RESIDENCY | ||
| 7 | At the start of the cycle, is patient residency primarily in U.S.? ⃝Yes ⃝ No ⃝ Refused | ||
| 7A | 
				 City of primary residence U.S. zip code at primary residence |__|__|__|__|__| OR 
 | ||
| 
				 | INTENT | ||
| 8 | Intended type of ART? Select all that apply: IVF: Transcervical GIFT: Gametes to tubes ZIFT: Zygotes to tubes or TET: tubal embryo transfer Oocyte or embryo banking | ||
| 9 | [SKIP IF NOT A BANKING ONLY CYCLE] | If cycle is for banking only, specify banking type (select all that apply): Embryo banking Autologous oocyte banking Donor oocyte banking | |
| 9A | Indicate anticipated duration of oocyte banking SKIP IF EMBRYO BANKING ONLY Short term (<12 months) Long term (≥12 months) banking for fertility preservation prior to gonadotoxic medical treatments Long term (≥12 months) banking for other reasons | ||
| 9B | Indicate anticipated duration of embryo banking SKIP IF OOCYTE BANKING ONLY Short term (<12 months) 
 Long term (≥12 months) banking for fertility preservation prior to gonadotoxic medical treatments Long term (≥12 months) banking for other reasons 
 | ||
| 10 | Intended embryo source (select all that apply): [IF ONLY DONOR EMBRYOS SELECTED, SKIP TO #12] Patient embryos Donor embryos Fresh embryos Frozen embryos 
 | ||
| 10A | If intent is to use FRESH EMBRYOS, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes 
 Fresh donor oocytes Frozen donor oocytes 
 If intent is to use FROZEN EMBRYOS, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes 
 Fresh donor oocytes Frozen donor oocytes Unknown (select only if oocyte source is unknown) | ||
| 10B | If intend is to use donor embryos (select all that apply): Fresh embryos Frozen embryos | ||
| 11 | Specify intended sperm source. Select all that apply. [SKIP IF DONOR EMBRYO IS INTENDED SOURCE] Partner Donor Patient, if male Unknown (select only if all sperm sources unknown for frozen) | ||
| 12 | Pregnancy carrier Patient Gestational carrier None (oocyte or embryo banking cycle only) | ||
| CYCLE INFORMATION (NOT prosPEctive FROM HERE FORWARD) | |
| Quex ID | LEAD QUESTION | 
| 13 | Type of ART performed? Select all that apply: IVF: Transcervical GIFT: Gametes to tubes ZIFT: Zygotes to tubes or TET: tubal embryo transfer Oocyte or embryo banking | 
| 14 | Embryo source (select all that apply): [IF ONLY DONOR EMBRYOS SELECTED, SKIP TO #15] Patient embryos Donor embryos Fresh embryos Frozen embryos 
 | 
| 14A | If FRESH EMBRYOS were used, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes 
 Fresh donor oocytes Frozen donor oocytes 
 If FROZEN EMBRYOS were used, specify intended oocyte source. Select all that apply: Fresh patient oocytes Frozen patient oocytes 
 Fresh donor oocytes Frozen donor oocytes Unknown (select only if oocyte source is unknown) | 
| PATIENT MEDICAL EVALUATION | ||||
| 
			 | REASON FOR ART | |||
| Quex ID | LEAD QUESTION | |||
| 15 | Reason for ART (Select all that apply): Male infertility (select all that apply) | |||
| [SKIP IF MALE INFERTILITY NOT SELECTED] | 
 Azoospermia, obstructive Azoospermia, non-obstructive Oligospermia, severe (<5 million/mL) Oligospermia, moderate (5-15 million/mL) Low motility (<40%) Low morphology (4%) 
 
 | |||
| History of endometriosis Tubal ligation for contraception Current or prior hydrosalpinx | ||||
| [SKIP IF HYDROSALPINX NOT SELECTED] | Communicating Occluded Unknown | |||
| Other tubal disease (not current or historic hydrosalpinx) Ovulatory disorders | ||||
| [SKIP IF OVULATORY DISORDER NOT SELECTED] | PCO Other ovulatory disorders | |||
| Diminished ovarian reserve Uterine factor Preimplantation Genetic Diagnosis as primary reason for ART Oocyte or Embryo Banking as reason for ART Indication for use of gestational carrier | ||||
| [SKIP IF GESTATIONAL CARRIER NOT INDICATED] | 
 
 | |||
| Recurrent pregnancy loss Other reasons related to infertility (specify) ________ _________ _______ Other reasons not related to infertility (specify) ________ _________ _______ Unexplained infertility | ||||
| 
			 | FEMALE PATIENT HISTORY AND PHYSICAL | |||
| 16 | [IF SEX OF PATIENT = MALE (FROM QUESTION #5) THEN SKIP #16-23] 
 Height: |__| Feet and/or |__|__| Inches or |__|__|__|__| Centimeters or Height unknown | |||
| 17 | Weight at the start of this cycle |__|__|__|__| Pounds or |__|__|__|__| Kilograms or Weight unknown | |||
| 18 | History of cigarette smoking: Did the patient smoke during the 3 months before the cycle started? 
 Yes No Unknown | |||
| 19 | Any prior pregnancies? ⃝Yes ⃝ No | |||
| 19A | [SKIP IF NO PRIOR PREGNANCIES] If prior pregnancies reported and couple is not surgically sterile, enter months or years attempting pregnancy since last clinical pregnancy |__|__|__| months and/or |__|__| years 
 [SKIP IF ANY PRIOR PREGNANCIES] If no prior pregnancies reported and couple is not surgically sterile, enter months attempting pregnancy |__|__|__| months and/or |__|__| years | |||
| 19B | SKIP IF NO PRIOR PREGNANCIES | If prior pregnancies reported, how many |__|__| | ||
| 19C | Number of prior full term births |__|__| | |||
| 19D | Number of prior preterm births |__|__| | |||
| 19E | Number of prior stillbirths |__|__| | |||
| 19F | Number of prior spontaneous abortions |__|__| | |||
| 19G | Number of ectopic pregnancies |__|__| | |||
| 20 | Number of prior stimulations for ART: |__|__| | |||
| 21 | Number of prior frozen ART cycles: |__|__| | |||
| 21A | SKIP IF NO PRIOR ART CYCLES | Did any of the prior ART cycles result in a live birth? ⃝Yes ⃝ No | ||
| 22 | Patient maximum FSH level (MIU/mls): |__|__|__| . |__|__| Or FSH unknown: | |||
| 23 | Most recent AMH level (ng/mL): |__|__|__| . |__|__| Or AMH unknown: 
 Date of most recent AMH level |__|__| - |__|__| - |__|__|__|__| 
 | |||
| SOURCE AND CARRIER PROFILES | ||||
| 
			 | OOCYTE SOURCE PROFILE | |||
| Quex ID | LEAD QUESTION | |||
| 24A | [IF OOCYTE SOURCE = PATIENT AND DONOR, ANSWER THIS QUESTION] Youngest oocyte source 
 Patient [SKIP TO Q25] Donor [CONTINUE TO Q24) | |||
| 24B | OOCYTE SOURCE Date of Birth (mm/dd/yyyy): [FIELD PRE-FILLED IF OOCYTE SOURCE=PATIENT] |__|__| - |__|__| - |__|__|__|__| 
 OR age at earliest time oocytes were retrieved ____ | |||
| 25 | OOCYTE SOURCE Ethnicity: Select one: NOT Hispanic or Latino Hispanic or Latino Refused Unknown 
 
 | |||
| 26 | OOCYTE SOURCE Race (based on oocyte source self-report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native | |||
| 26A | 
			 | Select reason race not reported: ⃝ Refused ⃝ Unknown 
 | ||
| 
			 | PREGNANCY CARRIER PROFILE | ||
| 27 | Pregnancy carrier Patient Gestational carrier None (oocyte or embryo banking cycle only) | ||
| 28 | [IF CARRIER=NONE THEN SKIP 28-31] or [IF CARRIER=PATIENT AND OOCYTE SOURCE=PATIENT THEN SKIP 28-31] 
 Pregnancy carrier Date of Birth (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| OR age at time of transfer ____ 
 | ||
| 29 | Pregnancy carrier Ethnicity: Select one: ⃝ NOT Hispanic or Latino ⃝ Hispanic or Latino ⃝ Refused ⃝ Unknown 
 | ||
| 30 | Pregnancy carrier Race (based on gestational carrier self report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native | ||
| 30A | Yes | 
			 | Select reason race not reported: ⃝ Refused ⃝ Unknown | 
| Quex ID | LEAD QUESTION | ||||||
| 
			 | SPERM SOURCE PROFILE | ||||||
| 31 | Specify sperm source. Select all that apply. Partner Donor Patient, if male Unknown (select only if all sperm sources unknown for frozen) | ||||||
| 32 | 
			 SPERM source Date of Birth (mm/dd/yyyy):|__|__| - |__|__| - |__|__|__|__| [FIELD PRE-FILLED IF SPERM SOURCE=MALE PATIENT] Or Unknown | ||||||
| 33 | SPERM source Ethnicity: Select one: ⃝ NOT Hispanic or Latino ⃝ Hispanic or Latino ⃝ Refused ⃝ Unknown | ||||||
| 34 | SPERM source Race (based on patient self report) Select all that apply: White Black or African American Asian Native Hawaiian or other Pacific Islander American Indian or Alaska Native | ||||||
| 34A | 
			 | Select reason race not reported: ⃝ Refused ⃝ Unknown | |||||
| STIMULATION AND RETRIEVAL | |||||||
| Quex ID | LEAD QUESTION | ||||||
| 
			 | OVARIAN STIMULATION AND MEDICATIONS | ||||||
| 35 | Was there stimulation for follicular development? [IF NO STIMULATION OR FROZEN CYCLE, SKIP #36-39] ⃝Yes ⃝ No 
 Was this a minimal stimulation cycle? 
 ⃝Yes ⃝ No 
 | ||||||
| 36 | Oral medication such as aromatase inhibitor or selective estrogen receptor modulator? ⃝Yes ⃝ No | ||||||
| 36A | [SKIP IF NO ORAL MEDS] | Clomiphene dosage (Total mgs): |__|__|__|__|__| . |__|__| Letrozole dosage (Total mgs) |__|__|__|__|__| . |__|__| Other (specify)_________ dosage |__|__|__|__|__| . |__|__| | |||||
| 37 | Medication(s) containing FSH? ⃝Yes ⃝ No | ||||||
| 37A | [SKIP IF NO FSH MEDS] | Short-acting FSH (Total IUs): |__|__|__|__|__| . |__|__| | |||||
| 37B | Long-acting FSH (Total mgs): |__|__|__|__|__| . |__|__| | ||||||
| 38 | Medication(s) with LH/HCG activity? ⃝Yes ⃝ No | ||||||
| Quex ID | LEAD QUESTION | ||||||
| 39 | GnRH Protocol Select the one primary protocol: ⃝ No GnRH protocol ⃝ GnRH Agonist Suppression ⃝ GnRH Agonist Flare ⃝ GnRH Antagonist Suppression | ||||||
| 
			 | CANCELLATION-I (open only for fresh cycles) | ||||||
| 40 | [IF OOCYTE/EMBRYO SOURCE = FROZEN THEN SKIP 40-45] 
 Was this ART cycle canceled prior to retrieval? ⃝Yes ⃝ No | ||||||
| 40A | [SKIP IF CYCLE NOT CANCELLED] | Date cycle canceled (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | |||||
| 40B | Select one primary reason cycle was canceled: Low ovarian response High ovarian response Inadequate endometrial response Concurrent illness Withdrawal only for personal reasons OTHER – specify ____________________________ | ||||||
| 
			 | [IF CYCLE CANCELLED, STOP HERE] | ||||||
| 
			 | FRESH OOCYTE RETRIEVAL | ||||||
| 41 | 
			 Date retrieval performed (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | ||||||
| 42 | Total number of patient oocytes retrieved: |__|__| | ||||||
| 43 | Total number of donor oocytes retrieved: |__|__| | ||||||
| 44 | Use of retrieved oocytes Select all that apply: Used for this cycle Oocytes frozen for future use Oocytes shared with other patients Embryos frozen for future use | ||||||
| 44A | [SKIP IF NO OOCYTES FROZEN] | Number of FRESH oocytes frozen for future use: |__|__| | |||||
| 
			 | COMPLICATIONS OF OVARIAN STIMULATION OR OOCYTE RETRIEVAL | 
 | |||||
| 45 | Were there any complications of ovarian stimulation or oocyte retrieval? ⃝Yes ⃝ No | ||||||
| 45A | SKIP IF NO COMPLICATIONS | Select all complications that apply: Infection Hemorrhage requiring transfusion Ovarian hyperstimulation requiring intervention or hospitalization Medication side effect Anesthetic complication Thrombosis Death of patient Other – specify ___________________ | |||||
| 45B | SKIP IF NO COMPLICATIONS | Did the complication(s) require hospitalization? ⃝Yes ⃝ No 
 | |||||
| 
			 | [IF OOCYTE BANKING CYCLE ONLY, STOP HERE] | ||||||
| 
			 | SPERM RETRIEVAL | |||
| 46 | Sperm status: Fresh Thawed Mix of fresh and thawed | |||
| 47 | Sperm source utilized: ⃝ Ejaculated ⃝ Epididymal ⃝ Testis ⃝ Electroejaculation ⃝ Retrograde urine ⃝ Donor ⃝ Unknown | |||
| LABORATORY INFORMATION | ||||
| Quex ID | LEAD QUESTION | |||
| 
			 | MANIPULATION | |||
| 48 | Intracytoplasmic sperm injection (ICSI) performed on oocytes? ⃝ All oocytes ⃝ Some oocytes ⃝ No oocytes ⃝ Unknown | |||
| 48A | SKIP IF NO ICSI | Indication for ICSI (select all that apply) ⃝ Prior failed fertilization ⃝ Poor fertilization ⃝ PGD ⃝ Abnormal semen parameters on day of fertilization ⃝ Low oocyte yield ⃝ Laboratory routine ⃝ Frozen cycle ⃝ Rescue ICSI ⃝ Other – specify ______________ | ||
| 49 | In vitro maturation (IVM) performed on oocytes? ⃝ All oocytes ⃝ Some oocytes ⃝ No oocytes ⃝ Unknown | |||
| 50 | Pre-implantation genetic diagnosis or screening performed on embryos? ⃝ Yes ⃝ No ⃝ Unknown | |||
| 50A | SKIP IF PGD/PGS NOT PERFORMED OR UNKNOWN | Total number of 2PN: |__|__| | ||
| 50B | Reason(s) for pre-implantation genetic diagnosis or screening (Select all that apply): Either genetic parent is a known carrier of a gene mutation or a chromosomal abnormality Aneuploidy screening of the embryos Elective Gender Determination Other screening of the embryos | |||
| 50C | Technique(s) used for pre-implantation genetic diagnosis or screening (Select all that apply): Polar Body Biopsy Blastomere Biopsy Blastocyst Biopsy Unknown | |||
| 51 | Assisted hatching performed on embryos? ⃝ All embryos ⃝ Some embryos ⃝ No embryos ⃝ Unknown | |||
| 52 | Was this a research cycle? ⃝ Yes Enter SART approval code_____________ ⃝ No | |||
| 52A | SKIP IF NOT RESEARCH CYCLE | Study type: Device study Protocol study Pharmaceutical study Laboratory technique Other research | ||
| 
			 | 
			 | If ‘Other’, please specify ______________________________ | ||
| 
			 | [IF EMBRYO BANKING CYCLE ONLY, SKIP TO #59, THEN STOP] | |||
| TRANSFER | ||||
| Quex ID | LEAD QUESTION | |||
| 
			 | CANCELLATION-II | |||
| 53 | Was a transfer attempted? ⃝Yes ⃝ No | |||
| 53A | 
			 | Select one primary reason no transfer was attempted: Low ovarian response High ovarian response Failure to survive oocyte thaw Inadequate endometrial response Concurrent illness Withdrawal only for personal reasons Unable to obtain sperm specimen Insufficient embryos OTHER – specify ____________________________ 
 | ||
| 
			 | [IF TRANSFER NOT ATTEMPTED, STOP HERE] | ||
| 
			 | GENERAL TRANSFER DETAILS | ||
| 54 | Date of embryo transfer (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | ||
| 55 | Endometrial thickness at trigger: |__|__|mm | ||
| 
			 | FRESH EMBRYO TRANSFER DETAILS | ||
| 56 | [IF NO FRESH EMBRYOS TRANSFERRED, SKIP #57-58] Number of FRESH embryos transferred to uterus: |__|__| | ||
| 57 | [SKIP #57 FOR MIXED CYCLE] If only one fresh embryo was transferred to the uterus, was this an elective single embryo transfer? ⃝Yes ⃝ No | ||
| 58A-X | Quality of embryo #1–X Good Fair Poor Unknown | ||
| 
			 | 
			 | Date of oocyte retrieval for embryo #1-X |__|__| - |__|__| - |__|__|__|__| | |
| 59 | Number of FRESH embryos cryopreserved: |__|__| [STOP HERE FOR EMBRYO BANKING ONLY CYCLE] | ||
| 
			 | THAWED EMBRYO TRANSFER DETAILS | 
 | |
| 60 | Number of FROZEN or THAWED embryos available on day of transfer: |__|__| | ||
| 61 | Number of THAWED embryos transferred to uterus: |__|__| [IF NO THAWED EMBRYOS TRANSFERRED, SKIP #62] | ||
| 62 | [SKIP #63 FOR MIXED CYCLE] If only one thawed embryo was transferred to the uterus, was this an elective single embryo transfer? ⃝Yes ⃝ No | ||
| 62A-X | Quality of embryo #1–X Good Fair Poor Unknown | ||
| 
			 | 
			 | Date of oocyte retrieval for embryo #1-X |__|__| - |__|__| - |__|__|__|__| | |
| 63 | Number of THAWED embryos cryopreserved (re-frozen): |__|__| | ||
| 
			 | GIFT/ZIFT/TET TRANSFER DETAILS | ||
| 64 | [SKIP IF IVF CYCLE] Number of oocytes or embryos transferred to the FALLOPIAN TUBE: |__|__| | ||
| TREATMENT OUTCOME (only opens if transfer >0) | |||
| Quex ID | LEAD QUESTION | ||
| 
			 | OUTCOME OF TRANSFER | ||
| 65 | Outcome of treatment cycle: Not pregnant Biochemical only Clinical intrauterine gestation Ectopic Heterotopic Unknown 
 [IF NOT PREGNANT, BIOCHEMICAL ONLY, ECTOPIC, OR HETEROTOPIC, STOP HERE] | ||
| 66 | 
			 | Maximum fetal hearts on ultrasound performed before 7 weeks or prior to reduction: |__|__| No ultrasound performed before 7 weeks gestation | |
| 66A | [SKIP IF NO U/S] | Date ultrasound with max. number of fetal hearts observed before 7 weeks (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| | |
| 66B | [SKIP IF NO U/S] | If 2 or more fetal hearts, any monochorionic twins or multiples? ⃝Yes ⃝ No ⃝Unknown | |
| PREGNANCY OUTCOME (only opens if pregnancy = yes) | |||
| Quex ID | LEAD QUESTION | ||
| 
			 | OUTCOME OF PREGNANCY | ||
| 67 | Outcome of pregnancy: Live birth Spontaneous abortion Stillbirth Induced abortion Maternal death prior to birth Outcome unknown | ||
| 68 | Date of pregnancy outcome (mm/dd/yyyy): |__|__| - |__|__| - |__|__|__|__| NOTE: If multiple births cover more than one date, enter date of first born. | ||
| 68A | Method of delivery Vaginal Cesarean section | ||
| 69 | Source of information confirming pregnancy outcome: (Select all that apply) Verbal confirmation from patient Written confirmation from patient Verbal confirmation from physician or hospital Written confirmation from physician or hospital | ||
| 
			 | BIRTH INFORMATION | 
 | |
| 70 | Number of infants born: |__|__| | ||
| 71A-X | Birth Status infant #1-X 
			Live birth 
 | ||
| 72A-X | Gender infant #1-X Male Female 
 | ||
| 73A-X | Weight in pounds and ounces, or grams infant #1-X |__|__| lbs and |__|__| oz. OR |__|__|__|__| g OR Weight unknown | ||
| 74A-X | Birth defects (select all that apply) infant #1-X None Cleft lip/palate Genetic defect/chromosomal abnormality Neural tube defect Cardiac defect Limb defect Other (specify) OR Unknown | ||
	
	
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document | 
| File Modified | 0000-00-00 | 
| File Created | 2021-01-22 |